BioCentury | Aug 6, 2012
Emerging Company Profile

Ascletis: Cash for China deals

...$50 million in the first tranche of a $100 million series A round from Qi's Hangzhou Binjiang Investment Holding...
...Hangzhou Minsheng Group Co. Ltd. Number of employees: 32 Funds raised: $50 million Investors: Hangzhou Binjiang Investment Holding...
BioCentury | Jan 19, 2012
Cover Story

Spreadin' the news

...million in the first tranche of a planned $100 million series A round led by Hangzhou Binjiang Investment Holding...
...and Institutions Mentioned Ascletis Inc. , Chapel Hill, N.C. Columbia University , New York, N.Y. Hangzhou Binjiang Investment Holding...
BioCentury | Apr 11, 2011
Finance

China-U.S. connection

...of global HIV drug discovery at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). The round was led by Hangzhou Binjiang Investment Holding...
BioCentury | Apr 11, 2011
Financial News

Ascletis completes venture financing

...Hill, N.C. Business: Cancer, Infectious Date completed: 4/6/11 Type: Venture financing Raised: $50 million Investors: Hangzhou Binjiang Investment Holding...
BioCentury | Apr 7, 2011
Top Story

Ascletis raises $50 million

...million in the first tranche of a planned $100 million series A round led by Hangzhou Binjiang Investment Holding...
Items per page:
1 - 5 of 5
BioCentury | Aug 6, 2012
Emerging Company Profile

Ascletis: Cash for China deals

...$50 million in the first tranche of a $100 million series A round from Qi's Hangzhou Binjiang Investment Holding...
...Hangzhou Minsheng Group Co. Ltd. Number of employees: 32 Funds raised: $50 million Investors: Hangzhou Binjiang Investment Holding...
BioCentury | Jan 19, 2012
Cover Story

Spreadin' the news

...million in the first tranche of a planned $100 million series A round led by Hangzhou Binjiang Investment Holding...
...and Institutions Mentioned Ascletis Inc. , Chapel Hill, N.C. Columbia University , New York, N.Y. Hangzhou Binjiang Investment Holding...
BioCentury | Apr 11, 2011
Finance

China-U.S. connection

...of global HIV drug discovery at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). The round was led by Hangzhou Binjiang Investment Holding...
BioCentury | Apr 11, 2011
Financial News

Ascletis completes venture financing

...Hill, N.C. Business: Cancer, Infectious Date completed: 4/6/11 Type: Venture financing Raised: $50 million Investors: Hangzhou Binjiang Investment Holding...
BioCentury | Apr 7, 2011
Top Story

Ascletis raises $50 million

...million in the first tranche of a planned $100 million series A round led by Hangzhou Binjiang Investment Holding...
Items per page:
1 - 5 of 5